Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Tranexamic Acid to Reduce Blood Loss in Reverse Total Shoulder Arthroplasty

NCT02043132 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.

NCT NCT02043132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02043132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Tranexamic Acid to Reduce Blood Loss in Reverse Total Shoulder Arthroplasty
Lead sponsor
Corewell Health East
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2013
Completion date
February 29, 2016
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood loss, surgical, complications; arthroplasty, intraoperative complications, shoulder joint disease